NCT01183234View on ClinicalTrials.gov

SPD544 High Strength Bioequivalence Study

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

August 27, 2010

Primary Completion Date

October 22, 2010

Study Completion Date

October 22, 2010

Conditions

ADHD

Interventions

DRUG

SPD544

two 30mg capsules, single oral dose

DRUG

Methylphenidate hydrochloride

one 60mg capsule, single oral dose

Trial Locations (1)

Unknown

Paraxel International, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Shire

INDUSTRY